FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Moody

Research Profile

Chemicals & Drugs

Anatomy

Living Beings

Procedures

Physiology

Drug Interactions

Disorders

Opioid-Related Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
David E Moody
Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine.
R Douglas Bruce; Marc N Gourevitch; David E Moody; Frederick L. Altice; Gerald H Friedland
A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.
R Douglas Bruce; Wenfang B Fang; Laurie Andrews; Diane Chodkowski; David E Moody; Jerdravee Morrison; Theresa L Parsons; Gerald H Friedland
Pharmacokinetic interactions between buprenorphine/naloxone and raltegravir in subjects receiving chronic buprenorphine/naloxone treatment.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Moody (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: David E Moody
Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine.
Expert opinion on drug metabolism & toxicology 2013;9(6):675-97.
2013: R Douglas Bruce; Marc N Gourevitch; David E Moody; Frederick L. Altice; Gerald H Friedland
A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice.
Expert review of clinical pharmacology 2013;6(3):249-69.
2013: R Douglas Bruce; Wenfang B Fang; Laurie Andrews; Diane Chodkowski; David E Moody; Jerdravee Morrison; Theresa L Parsons; Gerald H Friedland
Pharmacokinetic interactions between buprenorphine/naloxone and raltegravir in subjects receiving chronic buprenorphine/naloxone treatment.
The American journal of drug and alcohol abuse 2013;39(2):80-5.
2013: Elizabeth A Nunamaker; Wenfang B Fang; Lisa C Halliday; Matthew Lindeblad; David E Moody; Jeffrey D Fortman
Pharmacokinetics of 2 formulations of buprenorphine in macaques (Macaca mulatta and Macaca fascicularis).
Journal of the American Association for Laboratory Animal Science : JAALAS 2013;52(1):48-56.
2012: Michelle R Lofwall; David E Moody; P A Nuzzo; W B Fang; Sharon L Walsh
Pharmacokinetics of intranasal crushed OxyContin and intravenous oxycodone in nondependent prescription opioid abusers.
Journal of clinical pharmacology 2012;52(4):600-6.
2012: Valerie A Gruber; Qing Ma; Anika A.H. Alvanzo; David E Moody; Gene D Morse; Patricia Pade; Sudha Prathikanti; Petrie M Rainey; Elinore F McCance-Katz
Interactions between buprenorphine and the protease inhibitors darunavir-ritonavir and fosamprenavir-ritonavir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2012;54(3):414-23.
2011: Elinore F McCance-Katz; David E Moody; Sudha Prathikanti; Gerald Friedland; Petrie M Rainey
Rifampin, but not rifabutin, may produce opiate withdrawal in buprenorphine-maintained patients.
Drug and alcohol dependence 2011;118(2-3):326-34.
2011: David E Moody; Jerdravee Morrison; Wenfang B Fang; Elinore McCance-Katz
Gender differences in pharmacokinetics of maintenance dosed buprenorphine.
Drug and alcohol dependence 2011;118(2-3):479-83.
2011: Lisa S Middleton; David E Moody; Paul A Nuzzo; Michelle R Lofwall; Sharon L Walsh
The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers.
Addiction (Abingdon, England) 2011;106(8):1460-73.
2011: R Douglas Bruce; Diane Chodkowski; Wenfang B Fang; Laurie Andrews; David E Moody; Gerald H Friedland
Tipranavir/ritonavir induction of buprenorphine glucuronide metabolism in HIV-negative subjects chronically receiving buprenorphine/naloxone.
The American journal of drug and alcohol abuse 2011;37(4):224-8.
2011: Yan Chang; Wenfang B Fang; Shen-Nan Lin; David E Moody
Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.
Basic & clinical pharmacology & toxicology 2011;108(1):55-62.
2010: Robert Douglas Bruce; Frederick L. Altice; David E Moody; Gene D Morse; Laurie Andrews; Shen-Nan Lin; Wenfang B Fang; Qing Ma; Gerald H Friedland
Pharmacokinetic interactions between buprenorphine/naloxone and once-daily lopinavir/ritonavir.
Journal of acquired immune deficiency syndromes (1999) 2010;54(5):511-4.
2010: Elinore F McCance-Katz; Petrie M Rainey; David E Moody
Effect of cocaine use on buprenorphine pharmacokinetics in humans.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2010;19(1):38-46.
2010: Elinore F McCance-Katz; David E Moody; Gene D Morse; Qing Ma; Petrie M Rainey
Lack of clinically significant drug interactions between nevirapine and buprenorphine.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2010;19(1):30-7.
2010: Jennifer Baker; Petrie M Rainey; David E Moody; Gene D Morse; Qing Ma; Elinore F McCance-Katz
Interactions between buprenorphine and antiretrovirals: nucleos(t)ide reverse transcriptase inhibitors (NRTI) didanosine, lamivudine, and tenofovir.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2010;19(1):17-29.
2009: David E Moody; Wenfang B Fang; Shen-Nan Lin; Denise M Weyant; Stephen C Strom; Curtis J Omiecinski
Effect of rifampin and nelfinavir on the metabolism of methadone and buprenorphine in primary cultures of human hepatocytes.
Drug metabolism and disposition: the biological fate of chemicals 2009;37(12):2323-9.
2009: R Douglas Bruce; Frederick L. Altice; David E Moody; Shen-Nan Lin; Wenfang B Fang; John P Sabo; Jan M Wruck; Peter J Piliero; Carolyn Conner; Laurie Andrews; Gerald H Friedland
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone.
Drug and alcohol dependence 2009;105(3):234-9.
2009: Wenfang B Fang; Yan Chang; Elinore F McCance-Katz; David E Moody
Determination of naloxone and nornaloxone (noroxymorphone) by high-performance liquid chromatography-electrospray ionization- tandem mass spectrometry.
Journal of analytical toxicology 2009;33(8):409-17.
2009: David E Moody; Yan Chang; Wei Huang; Elinore F McCance-Katz
The in vivo response of novel buprenorphine metabolites, M1 and M3, to antiretroviral inducers and inhibitors of buprenorphine metabolism.
Basic & clinical pharmacology & toxicology 2009;105(3):211-5.
2009: Sharon L Walsh; William W Stoops; David E Moody; Shen-Nan Lin; George E Bigelow
Repeated dosing with oral cocaine in humans: assessment of direct effects, withdrawal, and pharmacokinetics.
Experimental and clinical psychopharmacology 2009;17(4):205-16.
2009: Shen-Nan Lin; Lolita Lamm; Thomas F Newton; Malcolm S Reid; David E Moody; Rodger Foltz
A liquid chromatography-electrospray ionization-tandem mass spectrometry method for quantitation of aripiprazole in human plasma.
Journal of analytical toxicology 2009;33(5):237-42.
2009: Yan Chang; David E Moody
Glucuronidation of buprenorphine and norbuprenorphine by human liver microsomes and UDP-glucuronosyltransferases.
Drug metabolism letters 2009;3(2):101-7.
2008: David E Moody; Shen-Nan Lin; Yan Chang; Lolita Lamm; Mark K Greenwald; Mahmoud S Ahmed
An enantiomer-selective liquid chromatography-tandem mass spectrometry method for methadone and EDDP validated for use in human plasma, urine, and liver microsomes.
Journal of analytical toxicology 2008;32(3):208-19.
2008: Lisa A Abbo; Jeff C H Ko; Lara K Maxwell; Raymond E Galinsky; David E Moody; Brenda M Johnson; Wenfang B Fang
Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs.
Veterinary therapeutics : research in applied veterinary medicine 2008;9(2):83-93.
2007: Elinore F McCance-Katz; David E Moody; Gene D Morse; Qing Ma; Robin DiFrancesco; Gerald Friedland; Patricia Pade; Petrie M Rainey
Interaction between buprenorphine and atazanavir or atazanavir/ritonavir.
Drug and alcohol dependence 2007;91(2-3):269-78.
2007: Robin DiFrancesco; Margaret A Fischl; Julie Donnelly; Barry S Zingman; Elinore F McCance-Katz; David E Moody; Richard C Reichman; Barbara Gripshover; Gene D Morse
Buprenorphine assay and plasma concentration monitoring in HIV-infected substance users.
Journal of pharmaceutical and biomedical analysis 2007;44(1):188-95.
2006: Elinore F McCance-Katz; David E Moody; Patrick F Smith; Gene D Morse; Gerald Friedland; Patricia Pade; Jennifer Baker; Anika A.H. Alvanzo; Peter Jatlow; Petrie M Rainey
Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43 Suppl 4():S235-46.
2006: Elinore F McCance-Katz; David E Moody; Gene D Morse; Gerald Friedland; Patricia Pade; Jennifer Baker; Anika A.H. Alvanzo; Patrick Smith; Abayomi Ogundele; Peter Jatlow; Petrie M Rainey
Interactions between buprenorphine and antiretrovirals. I. The nonnucleoside reverse-transcriptase inhibitors efavirenz and delavirdine.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43 Suppl 4():S224-34.
2006: R Douglas Bruce; Elinore F McCance-Katz; Evan D Kharasch; David E Moody; Gene D Morse
Pharmacokinetic interactions between buprenorphine and antiretroviral medications.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43 Suppl 4():S216-23.
2006: Wei Huang; David E Moody; Elinore F McCance-Katz
The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry.
Therapeutic drug monitoring 2006;28(2):245-51.
2006: Stacey C Sigmon; David E Moody; Elie S Nuwayser; George E Bigelow
An injection depot formulation of buprenorphine: extended bio-delivery and effects.
Addiction (Abingdon, England) 2006;101(3):420-32.
2006: Yan Chang; David E Moody; Elinore F McCance-Katz
Novel metabolites of buprenorphine detected in human liver microsomes and human urine.
Drug metabolism and disposition: the biological fate of chemicals 2006;34(3):440-8.
2006: David E Moody; Wenfang B Fang; David M Andrenyak; Kim M Monti; Chuck Jones
A comparative evaluation of the instant-view 5-panel test card with OnTrak TesTcup Pro 5: comparison with gas chromatography-mass spectrometry.
Journal of analytical toxicology 2006;30(1):50-6.
2005: Marek C Chawarski; David E Moody; Juliana Pakes; Patrick G O'Connor; Richard S Schottenfeld
Buprenorphine tablet versus liquid: a clinical trial comparing plasma levels, efficacy, and symptoms.
Journal of substance abuse treatment 2005;29(4):307-12.
2005: Meng Chen; David M Andrenyak; David E Moody; Rodger L Foltz
Determination of riboflavin by high-performance liquid chromatography with riboflavin-depleted urine as calibration and control matrix.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005;820(1):147-50.
2005: Wenfang B Fang; David M Andrenyak; David E Moody; Elie S Nuwayser
Determination of nalmefene by high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry.
Journal of analytical toxicology 2005;29(3):169-74.
2005: Yan Chang; David E Moody
Effect of benzodiazepines on the metabolism of buprenorphine in human liver microsomes.
European journal of clinical pharmacology 2005;60(12):875-81.
2004: David E Moody; John D Laycock; Wei Huang; Rodger L Foltz
A high-performance liquid chromatographic-atmospheric pressure chemical ionization-tandem mass spectrometric method for determination of risperidone and 9-hydroxyrisperidone in human plasma.
Journal of analytical toxicology 2004;28(6):494-7.
2004: Shen-Nan Lin; Yan Chang; David E Moody; Rodger L Foltz
A liquid chromatographic-electrospray-tandem mass spectrometric method for quantitation of quetiapine in human plasma and liver microsomes: application to study in vitro metabolism.
Journal of analytical toxicology 2004;28(6):443-8.
2004: David E Moody; Sharon L Walsh; Douglas E Rollins; Jennifer A Neff; Wei Huang
Ketoconazole, a cytochrome P450 3A4 inhibitor, markedly increases concentrations of levo-acetyl-alpha-methadol in opioid-naive individuals.
Clinical pharmacology and therapeutics 2004;76(2):154-66.
2004: Eric C Strain; David E Moody; Kenneth B Stoller; Sharon L Walsh; George E Bigelow
Relative bioavailability of different buprenorphine formulations under chronic dosing conditions.
Drug and alcohol dependence 2004;74(1):37-43.
2004: David E Moody; Alan C Spanbauer; James L Taccogno; Elizabeth K Smith
Comparative analysis of sweat patches for cocaine (and metabolites) by radioimmunoassay and gas chromatography-positive ion chemical ionization-mass spectrometry.
Journal of analytical toxicology 2004;28(2):86-93.
2003: Meng Chen; David M Andrenyak; David E Moody; Rodger L Foltz
Stability of plasma gamma-hydroxybutyrate determined by gas chromatography-positive ion chemical ionization-mass spectrometry.
Journal of analytical toxicology 2003;27(7):445-8.
2003: Shen-Nan Lin; Sharon L Walsh; David E Moody; Rodger L Foltz
Detection and time course of cocaine N-oxide and other cocaine metabolites in human plasma by liquid chromatography/tandem mass spectrometry.
Analytical chemistry 2003;75(16):4335-40.
2003: Christopher A Reilly; William J Ehlhardt; David A Jackson; Palaniappan Kulanthaivel; Abdul E Mutlib; Robert Espina; David E Moody; Dennis Crouch; Garold S Yost
Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells.
Chemical research in toxicology 2003;16(3):336-49.
2003: Wei Huang; Paul A Bemis; Matthew H Slawson; David E Moody
Determination of l-alpha-acetylmethadol (LAAM), norLAAM, and dinorLAAM in clinical and in vitro samples using liquid chromatography with electrospray ionization and tandem mass spectrometry.
Journal of pharmaceutical sciences 2003;92(1):10-20.
2002: Matthew H Slawson; James L Taccogno; Rodger L Foltz; David E Moody
Quantitative analysis of selegiline and three metabolites (N-desmethylselegiline, methamphetamine, and amphetamine) in human plasma by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.
Journal of analytical toxicology 2002;26(7):430-7.
2002: David E Moody; Matthew H Slawson; Eric C Strain; John D Laycock; Alan C Spanbauer; Rodger L Foltz
A liquid chromatographic-electrospray ionization-tandem mass spectrometric method for determination of buprenorphine, its metabolite, norbuprenorphine, and a coformulant, naloxone, that is suitable for in vivo and in vitro metabolism studies.
Analytical biochemistry 2002;306(1):31-9.
2002: Raymond G York; Kevin H Denny; David E Moody; Mario E Alburges
Developmental toxicity of levo-alpha-acetylmethadol (LAAM) in tolerant rats.
International journal of toxicology 2002;21(2):147-59.
2001: Wei Huang; David E Moody; David M Andrenyak; E K Smith; Rodger L Foltz; M A Huestis; J F Newton
Simultaneous determination of delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol in human plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry.
Journal of analytical toxicology 2001;25(7):531-7.
2001: Shen-Nan Lin; David E Moody; George E Bigelow; Rodger L Foltz
A validated liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for quantitation of cocaine and benzoylecgonine in human plasma.
Journal of analytical toxicology 2001;25(7):497-503.
2001: Jennifer A Neff; David E Moody
Differential N-demethylation of l-alpha-acetylmethadol (LAAM) and norLAAM by cytochrome P450s 2B6, 2C18, and 3A4.
Biochemical and biophysical research communications 2001;284(3):751-6.
2001: David E Moody; Matthew L. Cheever
Evaluation of immunoassays for semiquantitative detection of cocaine and metabolites or heroin and metabolites in extracts of sweat patches.
Journal of analytical toxicology 2001;25(3):190-7.
2001: A C Nelson; Wei Huang; David E Moody
Variables in human liver microsome preparation: impact on the kinetics of l-alpha-acetylmethadol (LAAM) n-demethylation and dextromethorphan O-demethylation.
Drug metabolism and disposition: the biological fate of chemicals 2001;29(3):319-25.
2000: Mei-Yee Law; David E Moody
Urinary excretion of 4-hydroxyamphetamine and amphetamine in male and female Sprague-Dawley and Dark Agouti rats following multiple doses of amphetamine.
Toxicology letters 2000;117(3):139-44.
2000: Alan C Spanbauer; David E Moody; Rodger L Foltz; Sharon L Walsh
A gas chromatographic-positive ion chemical ionization-mass spectrometric method for determination of cocaine, benzoylecgonine, ecgonine methyl ester, and norcocaine in plasma: detection of norcocaine in plasma after oral administration of cocaine.
Journal of analytical toxicology 2000;24(6):453-5.
2000: Mei-Yee Law; Matthew H Slawson; David E Moody
Selective involvement of cytochrome P450 2D subfamily in in vivo 4-hydroxylation of amphetamine in rat.
Drug metabolism and disposition: the biological fate of chemicals 2000;28(3):348-53.
1999: David E Moody; Kim M Monti; Alan C Spanbauer
Long-term stability of abused drugs and antiabuse chemotherapeutical agents stored at -20 degrees C.
Journal of analytical toxicology 1999;23(6):535-40.
1999: Shen-Nan Lin; David M Andrenyak; David E Moody; Rodger L Foltz
Enantioselective gas chromatography-negative ion chemical ionization mass spectrometry for methylphenidate in human plasma.
Journal of analytical toxicology 1999;23(6):524-30.
1999: Matthew L. Cheever; G A Armendariz; David E Moody
Detection of methadone, LAAM, and their metabolites by methadone immunoassays.
Journal of analytical toxicology 1999;23(6):500-5.
1998: Bibhash C Paria; W Ma; David M Andrenyak; Patricia C Schmid; Harald H O Schmid; David E Moody; H Deng; A Makriyannis; Sudhansu K Dey
Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors.
Biology of reproduction 1998;58(6):1490-5.
1997: David E Moody; Mario E Alburges; Robert J Parker; J M Collins; John M Strong
The involvement of cytochrome P450 3A4 in the N-demethylation of L-alpha-acetylmethadol (LAAM), norLAAM, and methadone.
Drug metabolism and disposition: the biological fate of chemicals 1997;25(12):1347-53.
1997: David E Moody; John D Laycock; Alan C Spanbauer; Dennis Crouch; Rodger L Foltz; J L Josephs; Leslie Amass; Warren K Bickel
Determination of buprenorphine in human plasma by gas chromatography-positive ion chemical ionization mass spectrometry and liquid chromatography-tandem mass spectrometry.
Journal of analytical toxicology 1997;21(6):406-14.
1997: Wei Huang; David E Moody; Rodger L Foltz; Sharon L Walsh
Determination of naltrexone and 6-beta-naltrexol in plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry.
Journal of analytical toxicology 1997;21(4):252-7.
1997: Rodger L Foltz; C Botelho; SA Reuschel; D J Kuntz; David E Moody; G M Bristow
Comparison of immunoassays for semiquantitative measurement of benzoylecgonine in urine.
NIDA research monograph 1997;175():287-302.
1996: Mario E Alburges; W Huang; Rodger L Foltz; David E Moody
Determination of methadone and its N-demethylation metabolites in biological specimens by GC-PICI-MS.
Journal of analytical toxicology 1996;20(6):362-8.
1996: Matthew H Slawson; Michael R Franklin; David E Moody
Correlations of the induction of microsomal epoxide hydrolase activity with phase II drug conjugating enzyme activities in rat liver.
Toxicology letters 1996;85(1):29-34.
1995: Mario E Alburges; Rodger L Foltz; David E Moody
Determination of ibogaine and 12-hydroxy-ibogamine in plasma by gas chromatography-positive ion chemical ionization-mass spectrometry.
Journal of analytical toxicology 1995;19(6):381-6.
1995: Dennis Crouch; Mario E Alburges; Alan C Spanbauer; Douglas E Rollins; David E Moody
Analysis of cocaine and its metabolites from biological specimens using solid-phase extraction and positive ion chemical ionization mass spectrometry.
Journal of analytical toxicology 1995;19(6):352-8.
1995: David E Moody; Dennis Crouch; C O Sakashita; Mario E Alburges; K Minear; J E Schulthies; Rodger L Foltz
A gas chromatographic-positive ion chemical ionization-mass spectrometric method for the determination of I-alpha-acetylmethadol (LAAM), norLAAM, and dinorLAAM in plasma, urine, and tissue.
Journal of analytical toxicology 1995;19(6):343-51.
1995: W Huang; David E Moody
Immunoassay detection of benzodiazepines and benzodiazepine metabolites in blood.
Journal of analytical toxicology 1995;19(6):333-42.
1994: M Y Law; David E Moody
Urinary excretion of amphetamine and 4'-hydroxyamphetamine by Sprague Dawley and dark Agouti rats.
Life sciences 1994;54(15):1073-9.
1993: W Huang; David E Moody; David M Andrenyak; Douglas E Rollins
Immunoassay detection of nordiazepam, triazolam, lorazepam, and alprazolam in blood.
Journal of analytical toxicology 1993;17(6):365-9.
1993: Michael R Franklin; Matthew H Slawson; David E Moody
Selective induction of rat liver phase II enzymes by N-heterocycle analogues of phenanthrene: a response exhibiting high correlation between UDP-glucuronosyltransferase and microsomal epoxide hydrolase activities.
Xenobiotica; the fate of foreign compounds in biological systems 1993;23(3):267-77.
1993: J W Ho; David E Moody
Determination of tolbutamide hydroxylation in rat liver microsomes by high-performance liquid chromatography: effect of psychoactive drugs on in vitro activity.
Life sciences 1993;52(1):21-8.
1992: David E Moody; G G Gibson; David F Grant; J Magdalou; M S Rao
Peroxisome proliferators, a unique set of drug-metabolizing enzyme inducers: commentary on a symposium.
Drug metabolism and disposition: the biological fate of chemicals 1992;20(6):779-91.
1992: Michael R Franklin; David E Moody
Concomitant induction of microsomal epoxide hydrolase and UDP-glucuronosyltransferase activities by dipyridine compounds.
Drug metabolism and disposition: the biological fate of chemicals 1992;20(5):726-9.
1992: David E Moody; K M Monti; Dennis Crouch
Analysis of forensic specimens for cannabinoids. II. Relationship between blood delta 9-tetrahydrocannabinol and blood and urine 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid concentrations.
Journal of analytical toxicology 1992;16(5):302-6.
1992: David E Moody; L F Rittenhouse; K M Monti
Analysis of forensic specimens for cannabinoids. I. Comparison of RIA and GC/MS analysis of blood.
Journal of analytical toxicology 1992;16(5):297-301.
1992: David E Moody
Effect of phenobarbital treatment on carbon tetrachloride-mediated cytochrome P-450 loss and diene conjugate formation.
Toxicology letters 1992;61(2-3):213-24.
1992: David E Moody; D N Loury; Bruce D Hammock; Boris Henry Ruebner; J M Cullen; J H Hillman; D W Hillman; M S Rao; W T London; H W Hann
Serum epoxide hydrolase (preneoplastic antigen) in human and experimental liver injury.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 1992;1(5):395-403.
1992: J W Ho; David E Moody
Gas chromatography/mass spectrometry assays for the determination of debrisoquine and sparteine metabolites in microsomal fractions of rat liver.
Analytical biochemistry 1992;203(2):348-51.
1991: David E Moody; B A Narloch; L R Shull; Bruce D Hammock
The effect of structurally divergent herbicides on mouse liver xenobiotic-metabolizing enzymes (P-450-dependent mono-oxygenases, epoxide hydrolases and glutathione S-transferases) and carnitine acetyltransferase.
Toxicology letters 1991;59(1-3):175-85.
1991: David E Moody; Dennis Crouch; R P Smith; C W Cresalia; P Francom; D G Wilkins; Douglas E Rollins
Drug and alcohol involvement in railroad accidents.
Journal of forensic sciences 1991;36(5):1474-84.
1991: David E Moody; K A Montgomery; M B Ashour; Bruce D Hammock
Effects of environmentally encountered epoxides on mouse liver epoxide-metabolizing enzymes.
Biochemical pharmacology 1991;41(11):1625-37.
1991: David E Moody; J K Reddy; B G Lake; J A Popp; D H Reese
Peroxisome proliferation and nongenotoxic carcinogenesis: commentary on a symposium.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1991;16(2):233-48.
1991: Mei-Yee Law; David E Moody
In vitro inhibition of mouse and rat glutathione S-transferases by di(2-ethylhexyl) phthalate, mono(2-ethylhexyl) phthalate, 2-ethylhexanol, 2-ethylhexanoic acid and clofibric acid.
Toxicology in vitro : an international journal published in association with BIBRA 1991;5(3):207-10.
1990: David E Moody; W Ruangyuttikarn; M Y Law
Quinidine inhibits in vivo metabolism of amphetamine in rats: impact upon correlation between GC/MS and immunoassay findings in rat urine.
Journal of analytical toxicology 1990;14(5):311-7.
1990: W Ruangyuttikarn; M Y Law; Douglas E Rollins; David E Moody
Detection of fentanyl and its analogs by enzyme-linked immunosorbent assay.
Journal of analytical toxicology 1990;14(3):160-4.
1990: David E Moody; J L James; E A Smuckler
Phenobarbital pretreatment alters the localization of CCl4-induced changes in rat liver microsomal fatty acids.
Toxicology and applied pharmacology 1990;103(1):16-27.
1990: David E Moody; Dennis Crouch; David M Andrenyak; R P Smith; D G Wilkins; A M Hoffman; Douglas E Rollins
Mandatory post-accident drug and alcohol testing for the Federal Railroad Administration: a comparison of results for two consecutive years.
NIDA research monograph 1990;100():79-96.
1989: David E Moody; Bruce D Hammock; Boris Henry Ruebner; D W Hillman; J H Hillman
Immunochemical comparison of human and rhesus monkey liver microsomal and the hepatocellular carcinoma-induced human serum epoxide hydrolases (preneoplastic antigens): basis for an enzyme-linked immunoabsorbent assay.
Carcinogenesis 1989;10(2):343-9.
1988: W Ruangyuttikarn; David E Moody
Comparison of three commercial amphetamine immunoassays for detection of methamphetamine, methylenedioxyamphetamine, methylenedioxymethamphetamine, and methylenedioxyethylamphetamine.
Journal of analytical toxicology 1988;12(4):229-33.
1988: David E Moody; G A Clawson; D A Geller; L A Taylor; J Button; D N Loury; Bruce D Hammock; E A Smuckler
Sodium cholate extraction of rat liver nuclear xenobiotic-metabolizing enzymes.
Biochemical pharmacology 1988;37(7):1331-41.
1988: David E Moody; L A Taylor; E A Smuckler
Differential inhibition of indirect immunofluorescence in rat liver sections incubated with antibodies against microsomal cytochromes P-450a, b, and c and epoxide hydrolase.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1988;36(3):291-5.
1987: David E Moody; Bruce D Hammock
Purification of microsomal epoxide hydrolase from liver of rhesus monkey: partial separation of cis- and trans-stilbene oxide hydrolase.
Archives of biochemistry and biophysics 1987;258(1):156-66.
1987: David E Moody; D N Loury; Bruce D Hammock
Immunochemical determination of microsomal epoxide hydrolase (preneoplastic antigen) in extrahepatic tissue.
Biochemical pharmacology 1987;36(4):570-2.
1987: D M Gillette; R D Corey; W G Helferich; J M McFarland; L J Lowenstine; David E Moody; Bruce D Hammock; L R Shull
Comparative toxicology of tetrachlorobiphenyls in mink and rats. I. Changes in hepatic enzyme activity and smooth endoplasmic reticulum volume.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1987;8(1):5-14.
1986: David E Moody; L A Taylor; E A Smuckler
Immunohistochemical evidence for alterations in specific forms of rat hepatic microsomal cytochrome P-450 during acute carbon tetrachloride intoxication.
Drug metabolism and disposition: the biological fate of chemicals 1986;14(6):709-13.
1986: W G Helferich; E G Carroad; M D Easter; David E Moody; Bruce D Hammock; L R Shull
Effect of medroxyprogesterone acetate on hepatic and placental drug metabolism in rats.
Biochemical pharmacology 1986;35(20):3655-8.
1986: David E Moody; M H Silva; Bruce D Hammock
Epoxide hydrolysis in the cytosol of rat liver, kidney, and testis. Measurement in the presence of glutathione and the effect of dietary clofibrate.
Biochemical pharmacology 1986;35(13):2073-80.
1986: David E Moody; B Head; C H Woo; J L James; E A Smuckler
NADPH-dependent and -independent loss of cytochrome P-450 in control and phenobarbital-induced rat hepatic microsomes incubated with carbon tetrachloride.
Experimental and molecular pathology 1986;44(3):318-28.
1986: Bruce D Hammock; G D Prestwich; D N Loury; P Y Cheung; W S Eng; S K Park; David E Moody; M H Silva; R N Wixtrom
Comparison of crude and affinity purified cytosolic epoxide hydrolases from hepatic tissue of control and clofibrate-fed mice.
Archives of biochemistry and biophysics 1986;244(1):292-309.
1985: D N Loury; David E Moody; B W Kim; Bruce D Hammock
Effect of dietary clofibrate on epoxide hydrolase activity in tissues of mice.
Biochemical pharmacology 1985;34(10):1827-33.
1985: David E Moody; D N Loury; Bruce D Hammock
Epoxide metabolism in the liver of mice treated with clofibrate (ethyl-alpha-(p-chlorophenoxyisobutyrate)), a peroxisome proliferator.
Toxicology and applied pharmacology 1985;78(3):351-62.
1985: David E Moody; L A Taylor; E A Smuckler
Immunofluorescent determination of the lobular distribution of a constitutive form of hepatic microsomal cytochrome P-450.
Hepatology (Baltimore, Md.) 1985;5(3):440-51.
1985: G D Prestwich; I Lucarelli; S K Park; D N Loury; David E Moody; Bruce D Hammock
Cyclopropyl oxiranes: reversible inhibitors of cytosolic and microsomal epoxide hydrolases.
Archives of biochemistry and biophysics 1985;237(2):361-72.
1984: Bruce D Hammock; D N Loury; David E Moody; Boris Henry Ruebner; R Baselt; K M Milam; P Volberding; A Ketterman; R Talcott
A methodology for the analysis of the preneoplastic antigen.
Carcinogenesis 1984;5(11):1467-73.
1983: David E Moody; L A Taylor; E A Smuckler; W Levin; P E Thomas
Immunohistochemical localization of cytochrome P-450a in liver sections from untreated rats and rats treated with phenobarbital or 3-methylcholanthrene.
Drug metabolism and disposition: the biological fate of chemicals 1983;11(4):339-43.
1982: David E Moody; G A Clawson; C H Woo; E A Smuckler
Cellular distribution of cytochrome P-450 loss in rats of different ages treated with alkyl halides.
Toxicology and applied pharmacology 1982;66(2):278-89.
1982: J L James; David E Moody; C H Chan; E A Smuckler
The phospholipids of the hepatic endoplasmic reticulum. Structural change in liver injury.
The Biochemical journal 1982;206(2):203-10.
1981: B Head; David E Moody; C H Woo; E A Smuckler
Alterations of specific forms of cytochrome P-450 in rat liver during acute carbon tetrachloride intoxication.
Toxicology and applied pharmacology 1981;61(2):286-95.
1981: David E Moody; J L James; G A Clawson; E A Smuckler
Correlations among the changes in hepatic microsomal components after intoxication with alkyl halides and other hepatotoxins.
Molecular pharmacology 1981;20(3):685-93.
1981: G A Clawson; David E Moody; C H Woo; E A Smuckler
Apparent differential response of nuclear envelope cytochrome P-450 following phenobarbital induction arising from a preferential loss during gradient purification.
Cancer research 1981;41(8):3122-7.
1980: David E Moody; J L James; E A Smuckler
Cytochrome P-450 lowering effect of alkyl halides, correlation with decrease in arachidonic acid.
Biochemical and biophysical research communications 1980;97(2):673-9.